Source · Select Committees · Women and Equalities Committee
Recommendation 33
33
Acknowledged
Paragraph: 121
Evaluate merits of nationally rolling out the anti-mullarian hormone blood test for PCOS diagnosis.
Conclusion
The approval of the anti-mullarian hormone blood test as another tool to assist in the diagnosis of polycycstic ovary syndrome is a welcome development. NHS England should evaluate the merits of rolling it out nationally as a matter of priority.
Government response summary AI-generated
The government stated it is working to take forward the Women’s Health Strategy for England and will consider the committee's recommendations on topics and key indicators, including the evaluation of the anti-mullarian hormone blood test, as part of this ongoing work.
Summary of the government's response below — read the verbatim text to verify.
Paragraph Reference:
121
Government Response
Acknowledged
HM Government · verbatim extract
Acknowledged
Polycystic ovary syndrome ( PCOS ) is a complex syndrome characterised by: multiple follicles in the ovary menstrual irregularity high testosterone levels Diagnosis is typically made using a combination of: medical history blood tests ultrasound scans While the anti-mullerian hormone ( AMH ) blood test may have potential, there would need to be further exploration of how it could add value in the diagnosis of PCOS . NHS England would first need to work with NICE to evaluate its impact on quality of care and cost-effectiveness to determine whether its broader implementation should be recommended. NICE has been asked to develop a clinical guideline on the assessment and management of PCOS and is now planning its development. Work in this area will include the diagnosis of PCOS , including consideration of AMH blood tests. NICE is exploring the possibility of collaboration with a reputable guidance-producing partner to enhance the speed and efficiency of this work. The progress of this guideline can be followed at Polycystic ovary syndrome: diagnosis and management .
Read the full response on Parliament ↗